Skip to main content

Fate Therapeutics, Inc. - Common Stock (NQ: FATE )

1.605 -0.055 (-3.31%)
Streaming Delayed Price Updated: 11:21 AM EST, Dec 26, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
May 09, 2018
Form S-3
Source: SEC/Edgar
May 03, 2018
Form 8-K
Source: SEC/Edgar
May 03, 2018
Form CT ORDER
Source: SEC/Edgar
March 18, 2018
Form DEFA14A
Source: SEC/Edgar
March 15, 2018
Form DEF 14A
Source: SEC/Edgar
March 15, 2018
Form S-8
Source: SEC/Edgar
March 07, 2018
Form 8-K
Source: SEC/Edgar
March 04, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 12, 2018
Form SC 13G/A
Source: SEC/Edgar
February 05, 2018
Form SC 13G/A
Source: SEC/Edgar
December 18, 2017
Form 8-K
Source: SEC/Edgar
December 13, 2017
Form 424B5
Source: SEC/Edgar
December 12, 2017
Form 424B5
Source: SEC/Edgar
December 11, 2017
Form 8-K
Source: SEC/Edgar
December 11, 2017
Form 8-K
Source: SEC/Edgar
October 31, 2017
Form EFFECT
Source: SEC/Edgar
August 24, 2017
Form S-8
Source: SEC/Edgar
August 14, 2017
Form S-3
Source: SEC/Edgar
August 14, 2017
Form 8-K
Source: SEC/Edgar
August 13, 2017
Form 8-K
Source: SEC/Edgar
July 13, 2017
Form 8-K
Source: SEC/Edgar
May 14, 2017
Form DEFA14A
Source: SEC/Edgar
March 21, 2017
Form DEF 14A
Source: SEC/Edgar
March 21, 2017
Form 8-K
Source: SEC/Edgar
March 15, 2017
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.